Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Dopamine Release in Depression
NCT02033369Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pramipexole in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Feb 2014; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02033369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033369.